<?xml version="1.0" encoding="UTF-8" standalone="yes"?><getRegulatorySnapshotOutput id="128723"><Title>Federal Register: Draft Guidance for Industry, Clinical Investigators, and Food and Drug Administration Staff; Design Considerations for Pivotal Clinical Investigations for Medical Devices; Availability (Notice), 15-Aug-2011</Title><Versions><Version>Final</Version></Versions><Status>Valid</Status><Abstract>The Food and Drug Administration (FDA) announced the availability of the draft guidance entitled ``Design Considerations for Pivotal Clinical Investigations for Medical Devices'' (IDRAC &lt;Link type="Regulatory" id="128565"&gt;128565&lt;/Link&gt;). This document is intended to provide guidance to those involved in designing clinical studies intended to support premarket submissions for medical devices and for FDA staff who review those submissions. This guidance document describes different study design principles relevant to the development of medical device clinical studies that can be used to fulfill premarket clinical data requirements. This draft guidance is not final nor is it in effect at this time.</Abstract><Region>USA</Region><Languages><language>English</language></Languages><Number>128723</Number><DocCategories><DocCategory>Reference Document</DocCategory></DocCategories><ProdCategories><ProdCategory>Drugs and Biologics</ProdCategory><ProdCategory>Medical Devices and IVDs</ProdCategory></ProdCategories><DocTypes><DocType>Federal Register Announcement</DocType><DocType>Guideline</DocType><DocType>Notice</DocType></DocTypes><Source>Volume 76, Number 157/Pages 50484 - 50485.&#xD;Docket No. FDA-2011-D-0567.&lt;br/&gt;http://www.accessdata.fda.gov&lt;br/&gt;15-AUG-2011</Source><DateDisplay>15-Aug-2011</DateDisplay><DocForm>0</DocForm><AddedDate>22-Aug-2011</AddedDate><LastUpdatedDate>05-May-2017 11:42:00</LastUpdatedDate><Topics><Topic>Clinical Trials</Topic><Topic>Pharmacovigilance Technovigilance Risk Management</Topic></Topics><MedicalDeviceSpecialties/></getRegulatorySnapshotOutput>